EYES Shares Outstanding History
Below is a table of the EYES shares outstanding history going back to 11/18/2014:

Date EYES Shares Outstanding
11/18/20144.33M
3/13/20154.42M
5/11/20154.42M
7/31/20154.48M
11/6/20154.48M
3/8/20164.50M
5/4/20164.50M
8/5/20165.27M
11/2/20165.28M
3/14/20177.05M
5/5/20177.05M
8/4/20177.10M
11/3/20177.10M
3/13/20187.48M
5/10/20188.33M
8/3/20188.38M
11/2/20189.10M
3/12/201915.52M
5/10/201915.52M
8/6/201915.57M
7/31/201928.87M
11/12/201915.57M
1/6/202015.57M
3/13/202015.66M
4/24/202015.66M
6/25/202023.12M
8/10/202023.12M
11/10/202023.12M
3/13/202123.25M
3/31/202127.91M
4/23/202127.91M
5/10/202127.91M
8/11/202139.41M

Also see: EYES Market Cap History
EYES YTD Return
EYES Historical Shares Outstanding:
+38.84% CAGR
EYES Historical Shares Outstanding: +38.84% CAGR

Mouse over chart for data details
11/18/2014 ...8/11/2021
Second Sight Medical Products develops, manufactures and markets implantable visual prosthetics that deliver artificial vision to blind individuals. Co. is developing the Orion® Visual Cortical Prosthesis System, an implanted cortical stimulation device which provides artificial vision to individuals who are blind due to a range of causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, or forms of cancer and trauma. Co.'s product, the Argus® II Retinal Prosthesis System, treats outer retinal degenerations, such as retinitis pigmentosa, a hereditary disease that causes a progressive degeneration of the light-sensitive cells of the retina. We show 33 historical shares outstanding datapoints in our coverage of EYES's shares outstanding history.

Understanding the changing numbers of EYES shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like EYES versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching EYES by allowing them to research EYES shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree EYES Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Second Sight Medical Products (EYES) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

EYPT Shares Outstanding History
FATE Shares Outstanding History
FBIO Shares Outstanding History
FBRX Shares Outstanding History
FCRE Shares Outstanding History
FCSC Shares Outstanding History
FDMT Shares Outstanding History
FEMY Shares Outstanding History
FGEN Shares Outstanding History
FHTX Shares Outstanding History
More Healthcare companies »

 

EYES Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.